December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
JazzCash Onboards Its 1 Millionth Merchant on Pakistan’s National Digital Payments Platform, Advancing the Country’s Cashless Economy
From VEON Ltd.
Via GlobeNewswire
Tickers VEON
News headline image
Lotus For Me SUV Officially Launches: Redefining Performance and Versatility with X-Hybrid Technology
From Lotus Technology Inc.
Via GlobeNewswire
Tickers LOT
News headline image
Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI
From UroGen Pharma Ltd.
Via GlobeNewswire
Tickers URGN
News headline image
HTVRONT Launches D2 DTF Printer to Simplify Small Business Production with a More “Worry-Free” Start
From HTVRONT
Via GlobeNewswire
News headline image
Aprea Therapeutics Highlights Positive Emerging Clinical Activity for WEE1 Inhibitor, APR-1051, with a Confirmed Partial Response in the Ongoing Phase 1 ACESOT-1051 Trial
From Aprea Therapeutics
Via GlobeNewswire
Tickers APRE
News headline image
Westwood Real Estate Income Fund Celebrates 25-Year Anniversary
From Westwood Holdings Group Inc
Via GlobeNewswire
Tickers WHG
News headline image
Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
From Eikon Therapeutics, Inc.
Via GlobeNewswire
Tickers EIKN
News headline image
Virtuix Signs Cooperative Research and Development Agreement with U.S. Navy
From Virtuix, Inc.
Via GlobeNewswire
Tickers VTIX
News headline image
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
From MediPharm Labs Corp.
Via GlobeNewswire
Tickers MEDIF TSX:LABS
News headline image
WISeKey’s WISeSat.Space Subsidiary Successfully Launches Its 21st Satellite to Low Earth Orbit with SpaceX
From Wisekey International Holding Ltd.
Via GlobeNewswire
Tickers WKEY
News headline image
Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
From Medicus Pharma Ltd
Via GlobeNewswire
Tickers MDCX
News headline image
Bombardier Announces Extension of Consent Solicitation with Respect to its 7.35% Debentures due 2026
From Bombardier Inc.
Via GlobeNewswire
Tickers BDRBF TSX:BBD-A TSX:BBD-B
News headline image
Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations
From Palvella Therapeutics Inc.
Via GlobeNewswire
Tickers PVLA
News headline image
BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9
From BridgeBio Pharma, Inc.
Via GlobeNewswire
Tickers BBIO
News headline image
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
From Biogen Inc.
Via GlobeNewswire
Tickers BIIB
News headline image
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From Bicara Therapeutics Inc.
Via GlobeNewswire
Tickers BCAX
News headline image
Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Tickers ASX ATHE
News headline image
Can-Fite’s Partner Vetbiolix Completes Enrollment in Phase 2 Osteoarthritis Study in Dogs Treated with Piclidenoson; Data Expected in Q3 2026
From Can-Fite BioPharma Ltd.
Via GlobeNewswire
News headline image
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
From Royalty Pharma plc
Via GlobeNewswire
Tickers RPRX
News headline image
urban-gro, Inc. Positions for Entry into Multi-Billion-Dollar T20 Cricket Market with LPL Season Six Player Auction on May 15, 2026 via IPG Platform
From Flash Sport & Media Inc
Via GlobeNewswire
Tickers UGRO
News headline image
PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
Connect Biopharma Announces $20.2 Million Private Placement Financing
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
News headline image
Micron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered
From Micron Biomedical
Via GlobeNewswire
News headline image
Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
News headline image
Priority Income Fund Announces 16.6% Annualized Total Cash Distribution Rate (on Net Asset Value) with Common Shareholder Distributions for March 2026 through May 2026
From Priority Income Fund, Inc.
Via GlobeNewswire
Tickers PSEC
News headline image
Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
News headline image
Digital Realty Announces Final Close of $3.25 billion U.S. Hyperscale Data Center Fund
From Digital Realty Trust, L.P.
Via GlobeNewswire
Tickers DLR
News headline image
AskNicely Launches Ask NiceAI®, a Breakthrough Tool to Turn Customer Feedback Into Revenue Growth
From AskNicely
Via GlobeNewswire
News headline image
Immusoft Awarded $15 Million in Funding from the California Institute for Regenerative Medicine
From Immusoft
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.